Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 5 studies | 19% ± 4% | |
intestine | 5 studies | 23% ± 7% | |
uterus | 5 studies | 20% ± 5% | |
pancreas | 4 studies | 36% ± 12% | |
eye | 4 studies | 28% ± 9% | |
breast | 4 studies | 20% ± 4% | |
kidney | 3 studies | 22% ± 6% | |
peripheral blood | 3 studies | 16% ± 1% | |
lymph node | 3 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 5785.09 | 226 / 226 | 100% | 86.90 | 405 / 406 |
breast | 100% | 2011.39 | 459 / 459 | 99% | 58.03 | 1109 / 1118 |
kidney | 100% | 2543.71 | 89 / 89 | 99% | 111.90 | 893 / 901 |
lung | 100% | 2821.19 | 577 / 578 | 99% | 64.40 | 1146 / 1155 |
pancreas | 100% | 4978.52 | 328 / 328 | 99% | 49.50 | 176 / 178 |
adrenal gland | 100% | 3522.61 | 258 / 258 | 99% | 155.04 | 227 / 230 |
esophagus | 100% | 1321.44 | 1441 / 1445 | 99% | 31.51 | 181 / 183 |
brain | 99% | 1776.74 | 2615 / 2642 | 100% | 70.52 | 702 / 705 |
thymus | 100% | 2613.18 | 653 / 653 | 98% | 78.95 | 595 / 605 |
prostate | 99% | 1935.36 | 243 / 245 | 99% | 75.35 | 497 / 502 |
ovary | 100% | 2459.68 | 180 / 180 | 98% | 32.82 | 422 / 430 |
stomach | 100% | 1738.17 | 359 / 359 | 98% | 36.30 | 279 / 286 |
uterus | 100% | 2055.82 | 170 / 170 | 97% | 36.04 | 443 / 459 |
intestine | 100% | 1564.39 | 963 / 966 | 97% | 40.81 | 510 / 527 |
bladder | 100% | 1920.43 | 21 / 21 | 92% | 35.00 | 466 / 504 |
skin | 99% | 1273.35 | 1782 / 1809 | 94% | 51.75 | 442 / 472 |
muscle | 100% | 2565.20 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1788.47 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 38.57 | 45 / 45 |
adipose | 100% | 2204.51 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2574.85 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 2825.38 | 827 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 28.81 | 26 / 29 |
peripheral blood | 77% | 1013.47 | 719 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 60% | 15.70 | 48 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1903895 | Biological process | negative regulation of IRE1-mediated unfolded protein response |
GO_0006986 | Biological process | response to unfolded protein |
GO_0002639 | Biological process | positive regulation of immunoglobulin production |
GO_0036503 | Biological process | ERAD pathway |
GO_0030183 | Biological process | B cell differentiation |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0005730 | Cellular component | nucleolus |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005737 | Cellular component | cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0030544 | Molecular function | Hsp70 protein binding |
GO_0051087 | Molecular function | protein-folding chaperone binding |
GO_0051787 | Molecular function | misfolded protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DNAJB9 |
Protein name | DnaJ homolog subfamily B member 9 (Endoplasmic reticulum DNA J domain-containing protein 4) (ER-resident protein ERdj4) (ERdj4) (Microvascular endothelial differentiation gene 1 protein) (Mdg-1) DnaJ homolog subfamily B member 9 (Endoplasmic reticulum DNA J domain-containing protein 4) |
Synonyms | UNQ743/PRO1471 MDG1 tcag7.15 hCG_17113 MST049 |
Description | FUNCTION: Co-chaperone for Hsp70 protein HSPA5/BiP that acts as a key repressor of the ERN1/IRE1-mediated unfolded protein response (UPR) (By similarity). J domain-containing co-chaperones stimulate the ATPase activity of Hsp70 proteins and are required for efficient substrate recognition by Hsp70 proteins . In the unstressed endoplasmic reticulum, interacts with the luminal region of ERN1/IRE1 and selectively recruits HSPA5/BiP: HSPA5/BiP disrupts the dimerization of the active ERN1/IRE1 luminal region, thereby inactivating ERN1/IRE1 (By similarity). Also involved in endoplasmic reticulum-associated degradation (ERAD) of misfolded proteins. Required for survival of B-cell progenitors and normal antibody production (By similarity). . |
Accessions | ENST00000249356.4 Q9UBS3 Q6FIF1 |